Dr. Keith Poscablo Guevarra, DO

Dr. Guevarra practices at University Hospital in Newark, New Jersey, part of State of New Jersey.

Dr. Guevarra's NPI, 1699925263, was assigned on September 19, 2008. Dr. Guevarra graduated from New York College of Osteo Medicine of New York Institute of Technology in 2005. Dr. Guevarra holds New Jersey license 25MB08952500.

Dr. Guevarra's primary practice is University Hospital, at 150 Bergen St, Newark, NJ 07103 in Essex County. The practice phone is (973) 972-4300.

Dr. Guevarra's primary practice is University Hospital in Newark, New Jersey, part of State of New Jersey. Dr. Guevarra is also affiliated with Newark Beth Israel Medical Center. The medical group on file is University Neuro-Ophthalmology Associates.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Guevarra practices, 2 sites in all. Vendor and product names are available with a free account.

Pulmonary disease is Dr. Guevarra's primary specialty in the NPI Registry, under taxonomy code 207RP1001X. Dmand AI has Dr. Guevarra's licenses on file in 2 states: New Jersey and New York.

CMS data shows 231 Medicare services from Dr. Guevarra across 3 procedure codes in 2024, for 129 Medicare patients. Medicare paid $35,868 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 129 Medicare patients who saw Dr. Guevarra in 2024. The largest group is 65 to 74, with 62 patients. 75% of them have high blood pressure, and 71% have high cholesterol. 64% are also on Medicaid. Their average risk score is 3.28, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Guevarra's median patient age at 62, with 52% women.

In 2024, Dr. Guevarra wrote 739 Medicare Part D claims for 76 patients. 34% of them were for generic drugs. CMS names the drug for 640 of them, across 10 drugs with 11 or more claims each, at $139,987 in total drug cost. In 2023, CMS named 729 claims across 15 drugs.

Dr. Guevarra accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 8 papers to Dr. Guevarra, published from 2013 to 2025. The most frequent topics are Critical Care, Echocardiography and Intensive Care Units. Dr. Guevarra has published most often in Cureus. Dr. Guevarra's most frequent co-authors are Yonatan Yosef Greenstein, MD, Morium Akthar, MD and Abhijith Hegde, MD.

Dmand AI links Dr. Guevarra to 1 clinical trial. Conditions studied include COVID-19 and Pneumonia, Viral.

CMS Open Payments shows 1 general payment to Dr. Guevarra from 1 drug or device company in 2025. Food and beverage make up the largest share, 100% of the total. Electromed, Inc. paid the most, $18.

Dr. Guevarra graduated from New York College of Osteo Medicine of New York Institute of Technology in 2005.